Pancreatic Neoplasms: all 3,311 studies

Page 13 of 34. Open to participants first (911), then studies with results posted, then the rest; newest registration first within each.

• Study of Stereotactic Body Radiation Therapy in Patients With Intact Pancreatic CancerCompletedNCT01342354Phase 1/2Results posted
• Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the PancreasTerminatedNCT01318642Phase 2Results posted
• Gemcitabine and CT-011 for Resected Pancreatic CancerTerminatedNCT01313416Phase 2Results posted
• A Trial Comparing Gemcitabine With and Without IMM-101 in Advanced Pancreatic CancerCompletedNCT01303172Phase 2Results posted
• Endoscopic Bipolar Radiofrequency Probe (ENDOHPB) in the Management of Unresectable Bile Duct and Pancreatic CancerTerminatedNCT01303159Not applicableResults posted
• Trial of ICM With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic CancerCompletedNCT01296763Phase 1Results posted
• Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP TrialCompletedNCT01294358Phase 1Results posted
• Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid TumorsCompletedNCT01286987Phase 1Results posted
• Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic CancerCompletedNCT01280058Phase 2Results posted
• Hydroxychloroquine in Previously Treated Patients With Metastatic Pancreatic CancerCompletedNCT01273805Phase 2Results posted
• Cancer in Patients With Gabapentin (GPRD)CompletedNCT01236053Results posted
• Gamma Secretase Inhibitor RO4929097 in Previously Treated Metastatic Pancreas CancerCompletedNCT01232829Phase 2Results posted
• QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the PancreasCompletedNCT01231347Phase 3Results posted
• PhII Study STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas CancerTerminatedNCT01227018Phase 2Results posted
• Selumetinib and Erlotinib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT01222689Phase 2Results posted
• A Study of Avastin (Bevacizumab) Added to a Chemotherapeutic Regimen in Patients With Metastatic Pancreatic CancerCompletedNCT01214720Phase 3Results posted
• Vismodegib and Gemcitabine Hydrochloride in Treating Patients With Advanced Pancreatic CancerCompletedNCT01195415Phase 2Results posted
• Gemcitabine/Cisplatin for Resected Pancreas Cancer: Establishing the Role of ERCC1 in Treatment DecisionTerminatedNCT01188109Phase 2Results posted
• Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD)CompletedNCT01138124Results posted
• Rapid Gastric and Pancreas Cancer Staging Utilizing Peritoneal LavageCompletedNCT01132755Phase 2Results posted
• Use of PET Imaging to Distinguish Malignant From Benign IPMNTerminatedNCT01104116Not applicableResults posted
• Secretin-Stimulated Magnetic Resonance Cholangiopancreatography (S-MRCP) in Pancreatic PatientsCompletedNCT01094561Not applicableResults posted
• Boost GVAX Pancreas Vaccine With or Without CY in Patients With Pancreas CancerActive, not recruitingNCT01088789Phase 2Results posted
• Gemcitabine and Pazopanib in Metastatic Pancreatic CancerTerminatedNCT01080248Phase 2Results posted
• Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic CancerCompletedNCT01064622Phase 2Results posted
• Panobinostat & Bortezomib in Pancreatic Cancer Progressing on Gemcitabine TherapyTerminatedNCT01056601Phase 2Results posted
• Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With GemcitabineCompletedNCT01020006Phase 2Results posted
• Early Increase in Blood Flow (EIBS) in the Duodenum in Patients With Pancreatic CancerCompletedNCT01015820Not applicableResults posted
• Study of Pazopanib and Ixabepilone in Patients With Solid TumorsTerminatedNCT01012362Phase 1Results posted
• Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell CancerCompletedNCT01010126Phase 2Results posted
• Study of Gemzar®, Taxotere®, and Xeloda® (GTX) in Patients With Metastatic Pancreatic Cancer (Stage IVB)CompletedNCT00996333Phase 2Results posted
• Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer PatientsCompletedNCT00966277Phase 4Results posted
• Evaluate the Efficacy and Safety of Activated T-lymphocyte Cell Therapy in Advanced Pancreatic CancerCompletedNCT00965718Phase 2Results posted
• Efavirenz as Second-Line Therapy in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00964171Phase 2Results posted
• Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine OriginTerminatedNCT00958841Phase 2Results posted
• Acceptability of Less Harmful Alternatives to CigarettesCompletedNCT00957424Not applicableResults posted
• ATX Study:A Study of Avastin (Bevacizumab), Tarceva (Erlotinib) and Xeloda (Capecitabine) in Patients With Locally Advanced and/or Metastatic Pancreatic CancerCompletedNCT00925769Phase 1Results posted
• Pre-Operative Staging of Pancreatic Cancer Using Superparamagnetic Iron Oxide Magnetic Resonance Imaging (SPIO MRI)CompletedNCT00920023Phase 4Results posted
• Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal CancerTerminatedNCT00903396Phase 2Results posted
• Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic CancerTerminatedNCT00889187Phase 1/2Results posted
• A Study of Gemzar, Taxotere, and Xeloda for Adjuvant Pancreatic CancerCompletedNCT00882310Phase 2Results posted
• Lapatinib and Capecitabine for Second Line Treatment of Pancreas CancerTerminatedNCT00881621Phase 2Results posted
• Combination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00871169Phase 2Results posted
• Study for Inoperable Non-Metastatic Pancreatic CA (Stage IVA) With Neoadjuvant GTX, and Radiation With GemzarCompletedNCT00869258Phase 2Results posted
• Study of Pemetrexed for Second-Line Pancreas CancerTerminatedNCT00864513Phase 2Results posted
• A Pilot Study Assessing Intra-Metastasis Administration of Autologous KLH-pulsed Dendritic Cells With Tumoral Radiation Therapy in Patients With Metastatic Pancreatic CarcinomaTerminatedNCT00843830Phase 1Results posted
• 7 Day's of Erlotinib Neo-adjuvant, Followed by Adjuvant Erlotinib-gemcitabine in Pancreatic Cancer PatientsTerminatedNCT00841035Phase 2Results posted
• A Study for Participants With Pancreatic CancerCompletedNCT00839332Phase 1/2Results posted
• Sorafenib and Erlotinib in Treating Patients With Pancreatic Cancer That Cannot Be Removed by SurgeryCompletedNCT00837876Phase 2Results posted
• Lenalidomide With Gemcitabine in Treatment of Untreated Advanced Carcinoma of the PancreasCompletedNCT00837031Phase 2Results posted
• Ipilimumab +/- Vaccine Therapy in Treating Patients With Locally Advanced, Unresectable or Metastatic Pancreatic CancerCompletedNCT00836407Phase 1Results posted
• Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine in Combination With Stereotactic RadiosurgeryTerminatedNCT00833859Phase 2Results posted
• Vorinostat Plus Radiation Therapy in Pancreatic CancerTerminatedNCT00831493Phase 1/2Results posted
• Gemcitabine and Erlotinib in Treating Patients With Metastatic or Recurrent Pancreatic CancerCompletedNCT00810719Phase 2Results posted
• Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop SmokingCompletedNCT00790569Not applicableResults posted
• Medical Nutrition Therapy or Standard Care in Treating Patients With Lung Cancer, Pancreatic Cancer, or Stage III or Stage IV Prostate CancerTerminatedNCT00769652Not applicableResults posted
• MK-0646 and Gemcitabine +/- Erlotinib for Patients With Advanced Pancreatic CancerCompletedNCT00769483Phase 1/2Results posted
• Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation TherapyTerminatedNCT00766636Phase 2Results posted
• Study of Low-Dose Fractionated Radiotherapy in Patients With Locally Advanced Metastatic Pancreatic CancerCompletedNCT00761345Phase 1Results posted
• Saracatinib in Treating Patients With Previously Treated Metastatic Pancreatic CancerCompletedNCT00735917Phase 2Results posted
• Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by SurgeryCompletedNCT00733746Phase 2Results posted
• Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by SurgeryCompletedNCT00727441Phase 2Results posted
• A Pilot Study, Evaluating the Efficacy of Regulatory T-cell Suppression by Ontak in Metastatic Pancreatic CancerTerminatedNCT00726037Phase 2Results posted
• Phase 1/2a DTA-H19 in Patients With Unresectable Pancreatic CancerCompletedNCT00711997Phase 1/2Results posted
• A Study On An Immunostimulant Antibody In Combination With Chemotherapy For Advanced Cancer Of The PancreasCompletedNCT00711191Phase 1Results posted
• Open, Randomized Phase II Trial to Investigate the Efficacy and Safety of the PLK-1 Inhibitor BI 2536 in Patients With Advanced, Unresectable Pancreatic CancerCompletedNCT00710710Phase 2Results posted
• APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic CancerCompletedNCT00709826Phase 2Results posted
• Study of Gemcitabine and Erlotinib Plus Sorafenib (GES) in Metastatic Pancreatic CancerCompletedNCT00696696Phase 2Results posted
• Abraxane Therapy in Patients With Pancreatic Cancer Who Failed First-Line Gemcitabine TherapyCompletedNCT00691054Phase 2Results posted
• Proton Therapy for Unresectable Cancer (CA) of PancreasCompletedNCT00685763Not applicableResults posted
• Human Leukocyte Antigen-A*02:01-restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic CancerTerminatedNCT00683085Phase 1/2Results posted
• Standardization of Surgery on the Pancreatic CancerCompletedNCT00679913Phase 3Results posted
• A Biomarker Identification Trial of Tarceva (Erlotinib) in Patients With Advanced Pancreatic CancerCompletedNCT00674973Phase 2Results posted
• Health Education Counseling With or Without Bupropion in Helping African Americans Stop SmokingCompletedNCT00666978Phase 4Results posted
• Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic NeoplasmsCompletedNCT00666926Phase 1Results posted
• Standard Pain Control or Intrathecal Therapy in Controlling Pain in Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic CancerTerminatedNCT00660348Not applicableResults posted
• A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic CancerCompletedNCT00652366Phase 2Results posted
• Phase 2 Study of S-1 in Advanced or Metastatic Pancreatic CancerCompletedNCT00651742Phase 2Results posted
• Erlotinib and RAD001 (Everolimus) in Patients With Previously Treated Advanced Pancreatic CancerTerminatedNCT00640978Phase 2Results posted
• Treatment of Cancer-anorexia Using Megestrol Acetate Concentrated Suspension in Lung or Pancreatic Cancer PatientsTerminatedNCT00637728Phase 3Results posted
• A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic CancerCompletedNCT00637247Phase 2Results posted
• CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary CarcinomaCompletedNCT00634751Phase 1/2Results posted
• QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic CancerCompletedNCT00630552Phase 1/2Results posted
• Monoclonal Antibody RAV12 and Gemcitabine in Treating Patients With Metastatic Pancreatic CancerTerminatedNCT00625586Phase 2Results posted
• S0727 Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By SurgeryCompletedNCT00617708Phase 1/2Results posted
• Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary EndpointTerminatedNCT00613730Phase 2Results posted
• Perioperative Therapy for Resectable Pancreatic CancerCompletedNCT00609336Phase 2Results posted
• Panitumumab, Chemotherapy, and External-Beam Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot be Removed by SurgeryCompletedNCT00601627Phase 2Results posted
• Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic CancerCompletedNCT00593866Phase 1/2Results posted
• Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain MetastasesCompletedNCT00587964Phase 2Results posted
• Endoscopic Ultrasound-guided Celiac Plexus Neurolysis (EUS-CPN)With Alcohol in Unresectable Pancreatic Cancer: a Pilot StudyCompletedNCT00578279Phase 4Results posted
• Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Stage IV Pancreatic CancerCompletedNCT00577889Phase 2Results posted
• Aflibercept Compared to Placebo in Term of Efficacy in Patients Treated With Gemcitabine for Metastatic Pancreatic CancerTerminatedNCT00574275Phase 3Results posted
• An Efficacy Study of MORAb-009 in Subjects With Pancreatic CancerCompletedNCT00570713Phase 2Results posted
• Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00550836Phase 2Results posted
• Dasatinib in Treating Patients With Stage IV Pancreatic CancerTerminatedNCT00544908Phase 2Results posted
• CC-4047 With Gemcitabine for Untreated Advanced Carcinoma of the PancreasCompletedNCT00540579Phase 1/2Results posted
• Gemcitabine and Oxaliplatin in Treating Patients With Pancreatic Cancer That Can Be Removed By SurgeryCompletedNCT00536874Phase 2Results posted
• Bupropion in Helping Adults Stop SmokingCompletedNCT00534001Phase 2Results posted
• Open-label Study of CS-1008 for Subjects With Untreated and Unresectable Pancreatic CancerCompletedNCT00521404Phase 2Results posted

← Pancreatic Neoplasms overview